Approval · Notice of Compliance 17784 · 2016
VISANNE: Notice of Compliance 17784
Issued February 18, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17784
- Date
- February 18, 2016
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication to include management of pain associated with endometriosis in pediatric patients under the age of 18 and after menarche
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISANNE | Not yet assigned | — |
Medicinal ingredients
- DIENOGEST 2 MG per TAB